测定咖啡因代谢物评价N-乙酰转移酶、CYP1A2和黄嘌呤氧化酶活性  被引量:10

DETERMINATION OF CAFFEINE METABOLITE FOR THE EVALUATION OF N ACETYLTRANSFERASE, CYP1A2 AND XANTHINE OXIDASE ACTIVITIES *

在线阅读下载全文

作  者:卢建丰[1] 易涛[1] 曹晓梅[1] 卓海通[1] 凌树森[1] 

机构地区:[1]南京军区南京总医院临床药理科

出  处:《药学学报》1997年第11期813-818,共6页Acta Pharmaceutica Sinica

基  金:国家自然科学基金

摘  要:目的是对中国人N乙酰化酶(NAT2)、CYP1A2酶和黄嘌呤氧化酶(XO)的活性进行分析。120名健康志愿者饮用3杯咖啡后于4~5h留尿,用HPLC方法测定尿中5种咖啡因主要代谢物浓度,即5乙酰胺基6甲酰胺基3甲基尿嘧啶(AFMU)、1甲基黄嘌呤(1X)、1甲基尿酸(1U)、1,7二甲基尿酸(17X)、1,7二甲基黄嘌呤(17U)。其中N乙酰化酶活性用AFMU/1X或AFMU/(AFMU+1X+1U)表示;CYP1A2酶活性指标采用(AFMU+1X+1U)/17X或AFMU+1X+1U)/17U;XO酶活性指标采用1U/1X或1U/(1X+1U)。结果表明,N乙酰化酶活性呈两态分布,慢代谢者占167%,CYP1A2和XO酶活性呈对数正态分布,其代谢比值与国外文献报道一致。提示通过测定咖啡因代谢物比值,可以进行NAT2酶、CYP1A2酶和黄嘌呤氧化酶活性分析。Caffeine was used as a metabolic probe to measure, in 120 healthy volunteers, the activities of three enzymes, deduced to be N acetyltransferase(NAT2), CYP1A2 and xanthine oxidase(XO). The caffeine metabolites of 5 acetylamino 6 formylamino 3 methyluracil(AFMU), 1 methylxanthine(1X), 1 methyluric acid(1U), 1,7 dimethylxanthine(17X), and 1,7 dimethyluric acid(17U) in urine were determined with HPLC after 4~5 hours of caffeine drink. The ratios of AFMU/1X or AFMU/(AFMU+1X+1U), (AFMU+1X+1U)/17X or (AFMU+1X+1U)/17U, and 1U/1X or 1U/(1X+1U) were used as the index of NAT2, CYP1A2, and XO activities respectively. Frequency distribution analysis of the metabolic ratios of NAT2 indicated two distinct group with 20 slow acetylators and 100 rapid acetylators. Similar CYP1A2 activity was found in Chinese compared with European volunteers. Frequency analysis of CYP1A2 indicated the log normal distribution in 120 Chinese. The CYP1A2 index was much higher in smokers than that in non smokers. But no obvious difference was observed between young and old volunteers. The XO index also showed log normal distribution and has the similar value compared with European volunteers. The concentration variations of 1X and 1U in young volunteers were much lower than that in old volunteers.

关 键 词:咖啡因 N-乙酰化酶 CYP1A2酶 黄嘌呤氧化酶 

分 类 号:R971.7[医药卫生—药品]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象